<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11-pharmaceuticals-13-00455">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Howells</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Iwuji</surname>
    <given-names>C.O.</given-names>
   </name>
   <name>
    <surname>Irving</surname>
    <given-names>G.R.B.</given-names>
   </name>
   <name>
    <surname>Barber</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Walter</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sidat</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Griffin-Teall</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Foreman</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>S.R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial</article-title>
  <source>J. Nutr.</source>
  <year>2019</year>
  <volume>149</volume>
  <fpage>1133</fpage>
  <lpage>1139</lpage>
  <pub-id pub-id-type="doi">10.1093/jn/nxz029</pub-id>
  <?supplied-pmid 31132111?>
  <pub-id pub-id-type="pmid">31132111</pub-id>
 </element-citation>
</ref>
